Pharmaceuticals

Global mRNA Therapeutics Market 2025–2029: Competitive Insights and Opportunities

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The mRNA Therapeutics Industry By The Forecast Year 2029?

The mRNA therapeutics market size has shown steady growth over recent years. Its expansion is anticipated to be from $34.76 billion in 2024 to $35.9 billion in 2025, with a compound annual growth rate (CAGR) of 3.3%. This historical growth can be attributed to increased financial investment in the development of effective pharmaceuticals and vaccines, the growth of federal initiatives aimed at promoting RNA-based medicines, greater understanding of rare genetic diseases, and an increase in clinical trial activity.

The mRNA therapeutics market is poised for consistent expansion over the upcoming years. Projections indicate its value will reach $41.08 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 3.4%. This anticipated growth during the forecast period stems from factors such as an escalating incidence of infectious diseases, a rise in patient visits to healthcare facilities, the broadening utility of mRNA therapeutics, increasing calls for personalized and precision medicine, supportive regulatory landscapes, and expedited approval processes. Key developments projected for this period encompass breakthroughs in mRNA delivery methods, the swift creation and adoption of mRNA vaccines, the introduction of self-amplifying mRNA (saRNA) systems, the adaptability and ease of scaling mRNA production, and the innovation of new mRNA modifications.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17205&type=smp

What Are The Main Drivers Boosting The mRNA Therapeutics Industry’s Expansion?

The increasing occurrence of long-lasting and communicable diseases is anticipated to drive the growth of the mRNA therapeutics market in the future. These illnesses are defined as conditions that endure for prolonged periods and can spread between individuals, encompassing examples such as tuberculosis, HIV/AIDS, and hepatitis. The rise in their prevalence is attributed to factors like heightened global travel and inadequate healthcare infrastructure, which together facilitate the transmission and complicate the effective management of these health issues. mRNA therapeutics prove beneficial for long-lasting and communicable diseases by quickly enabling the body to generate proteins that enhance immune responses, thus leading to faster development of vaccines and treatments. For instance, in October 2023, according to GOV.UK, a UK-based government website, in 2022, there were 94,397 people in England living with diagnosed HIV and receiving care, representing a 3% increase from the 91,368 individuals in 2021. This demonstrates how the expanding prevalence of long-lasting and communicable diseases is fueling the expansion of the mRNA therapeutics market.

How Is The mRNA Therapeutics Market Segmented?

The mrna therapeutics market covered in this report is segmented –

1) By Product: Vaccines, Drugs

2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications

3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses

Subsegments:

1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines

2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs

What Are The Major Trends Driving The Growth Of The mRNA Therapeutics Market?

Major companies operating in the mRNA therapeutics market are focusing on developing innovative solutions, such as mRNA-based booster vaccines, to enhance immunity against evolving viral variants. An mRNA-based booster vaccine refers to a vaccine that uses messenger RNA (mRNA) technology to enhance and prolong immunity against a specific pathogen, often after the initial vaccination series. For instance, in June 2023, Gennova Biopharmaceuticals Ltd., an India-based pharmaceutical company, launched India’s first indigenous mRNA-based Omicron-specific booster vaccine called GEMCOVAC-OM. This vaccine aims to provide a variant-specific solution capable of eliciting desired immune responses against the Omicron variant of SARS-CoV-2. GEMCOVAC-OM is thermostable, does not require ultra-cold chain infrastructure, and can be administered without a needle injection using a needle-free device system, making it easy for last-mile deployment in India. Clinical studies demonstrated that the vaccine generated significantly higher immune responses compared to other vaccines, underscoring the need for variant-specific vaccines to elicit desired immune responses.

Which Global Market Leaders Are Shaping The Future Of The mRNA Therapeutics Sector?

Major companies operating in the mRNA therapeutics market are Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The mRNA Therapeutics Market?

North America was the largest region in the mRNA therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The mRNA Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=17205&type=smp

Browse Through More Reports Similar to the Global mRNA Therapeutics Market 2025, By The Business Research Company

Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/messenger-ribonucleic-acid-mrna-synthesis-raw-materials-global-market-report

Leukemia Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/leukemia-therapeutics-global-market-report

Bipolar Disorder Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bipolar-disorder-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795